AI assistant
Sending…
Mirum Pharmaceuticals, Inc. — Director's Dealing 2021
Jun 8, 2021
31228_dirs_2021-06-08_4e0446ad-c001-4b63-8a28-0b16696c8670.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-06-04
Reporting Person: Brosgart Carol L (Director)
More from Mirum Pharmaceuticals, Inc.
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Annual Report
2026
Apr 24
M&A Activity
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18